Losing face? Take heart. A new supplement promises to put an end to the emaciated aesthetic of ‘Ozempic face.’ ...

GLP-1 drugs like Ozempic are injectable medications—but a strange new market has emerged selling oral “compounded” versions ...

However, the clock is ticking. Novo Nordisk already has an oral semaglutide to treat type 2 diabetes, sold under the brand ...

“The average woman gains about six to seven pounds during this menopausal transitional period,” says Daniel H. Bessesen, MD, ...

Canada's health regulator has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

Most patients still need to be managed by oral medications to treat diabetes and not injections, at least in the early stages ...

Popular weight loss drugs have been linked to gastrointestinal, mental health, and vision problems, but the benefits appear ...

The FDA’s decision to allow the compounding of GLP-1 weight loss drugs could undermine its public health obligations, writes ...

To understand why compounding pharmacists can make copies of semaglutide (the key ingredient in Ozempic ... For example, they ...